How Well Does A New Alzheimer's Drug Work For...

Have you ever wanted to be an astronaut without risking your life in space? If so, we have the perfect opportunity for you. NASA is calling for people with a science background to apply for a simulated mission to the Moon and Mars. Four adults will spend a year isolated in two en ...  Show more

With parts of the U.S, Canada, Spain and France all ablaze with wildfires, you might be wondering: Are wildfires on the rise? If so, know that you mind-melded with the entire Short Wave staff. We had the exact same thought – and then went down some reporting rabbit holes and turn ...  Show more

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  Show more

A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ...  Show more

Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ...  Show more